Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Elekta price target lowered to SEK 83 from SEK 88 at JPMorgan » 13:05
10/26/20
10/26
13:05
10/26/20
13:05
EKTAY

Elekta

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington lowered the firm's price target on Elekta to SEK 83 from SEK 88 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/09/20 Morgan Stanley
Elekta price target raised to SEK 91 from SEK 86 at Morgan Stanley
09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
Over a month ago
Conference/Events
Morgan Stanley to hold a virtual conference » 08:13
09/15/20
09/15
08:13
09/15/20
08:13
TAK

Takeda Pharmaceutical

$18.37 /

+0.03 (+0.16%)

, CVS

CVS Health

$57.93 /

+0.52 (+0.91%)

, FRLN

Freeline

$17.00 /

-0.005 (-0.03%)

, TMO

Thermo Fisher

$433.94 /

+3.4 (+0.79%)

, MCK

McKesson

$150.95 /

+0.495 (+0.33%)

, HAE

Haemonetics

$89.58 /

+0.795 (+0.90%)

, RGNX

Regenxbio

$28.67 /

+1.65 (+6.11%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

, INSM

Insmed

$30.38 /

+2.03 (+7.16%)

, MRK

Merck

$84.18 /

+0.93 (+1.12%)

, EKTAY

Elekta

$0.00 /

+ (+0.00%)

, RPTX

Repare Therapeutics

$33.20 /

+3.23 (+10.78%)

, BLI

Berkeley Lights

$60.12 /

+1.04 (+1.76%)

, DXCM

DexCom

$393.34 /

+9.62 (+2.51%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, LEGN

Legend Biotech

$32.29 /

+1.24 (+3.99%)

, IRTC

iRhythm

$220.30 /

+10.57 (+5.04%)

, HOOK

Hookipa Pharma

$11.18 /

+1.55 (+16.10%)

, BLUE

Bluebird Bio

$54.06 /

+0.77 (+1.44%)

, SRPT

Sarepta

$138.60 /

+7.935 (+6.07%)

, MRNS

Marinus Pharmaceuticals

$2.10 /

+0.1 (+5.00%)

, ISRG

Intuitive Surgical

$717.15 /

+14.79 (+2.11%)

18th Annual Global…

18th Annual Global Healthcare Virtual Conference will be held on September 14-18 with webcasted presentations to begin on September 15 at 8 am. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

TAK Takeda Pharmaceutical
$18.37 /

+0.03 (+0.16%)

SRPT Sarepta
$138.60 /

+7.935 (+6.07%)

RPTX Repare Therapeutics
$33.20 /

+3.23 (+10.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RGNX Regenxbio
$28.67 /

+1.65 (+6.11%)

MRNS Marinus Pharmaceuticals
$2.10 /

+0.1 (+5.00%)

MRK Merck
$84.18 /

+0.93 (+1.12%)

MCK McKesson
$150.95 /

+0.495 (+0.33%)

LEGN Legend Biotech
$32.29 /

+1.24 (+3.99%)

ISRG Intuitive Surgical
$717.15 /

+14.79 (+2.11%)

IRTC iRhythm
$220.30 /

+10.57 (+5.04%)

INSM Insmed
$30.38 /

+2.03 (+7.16%)

HOOK Hookipa Pharma
$11.18 /

+1.55 (+16.10%)

HAE Haemonetics
$89.58 /

+0.795 (+0.90%)

FRLN Freeline
$17.00 /

-0.005 (-0.03%)

DXCM DexCom
$393.34 /

+9.62 (+2.51%)

CVS CVS Health
$57.93 /

+0.52 (+0.91%)

BLUE Bluebird Bio
$54.06 /

+0.77 (+1.44%)

TAK Takeda Pharmaceutical
$18.37 /

+0.03 (+0.16%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
CVS CVS Health
$57.93 /

+0.52 (+0.91%)

08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
FRLN Freeline
$17.00 /

-0.005 (-0.03%)

09/01/20 Evercore ISI
Freeline initiated with an Outperform at Evercore ISI
09/01/20 Wedbush
Wedbush bullish on Freeline, initiates with an Outperform
09/01/20 Wedbush
Freeline initiated with an Outperform at Wedbush
09/01/20 Morgan Stanley
Freeline initiated with an Overweight at Morgan Stanley
TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

09/14/20 Morgan Stanley
Thermo Fisher initiated with an Overweight at Morgan Stanley
09/11/20 Citi
Thermo Fisher price target raised to $485 from $471 at Citi
09/09/20 Benchmark
Inovio LOI 'effectively puts to bed' doubts about manufacturing, says Benchmark
08/24/20 Citi
Qiagen upgraded to Buy from Neutral at Citi
MCK McKesson
$150.95 /

+0.495 (+0.33%)

08/04/20
Fly Intel: Top five analyst upgrades
08/04/20 JPMorgan
McKesson price target raised to $198 from $187 at JPMorgan
08/04/20 Deutsche Bank
Deutsche Bank upgrades McKesson to Buy after 'solid' Q1 beat
08/04/20 Deutsche Bank
McKesson upgraded to Buy from Hold at Deutsche Bank
HAE Haemonetics
$89.58 /

+0.795 (+0.90%)

07/01/20 Raymond James
Haemonetics price target lowered to $113 from $125 at Raymond James
05/06/20 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
04/07/20 Raymond James
Haemonetics price target lowered to $130 from $150 at Raymond James
03/20/20 Jefferies
Haemonetics 'key strategic provider' for plasma COVID approaches, says Jefferies
RGNX Regenxbio
$28.67 /

+1.65 (+6.11%)

08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/25/20 BofA
Regenxbio reinstated with a Buy at BofA
05/12/20 RBC Capital
Regenxbio initiated with a Sector Perform at RBC Capital
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
INSM Insmed
$30.38 /

+2.03 (+7.16%)

04/23/20 JMP Securities
JMP reiterates $50 target on Insmed on planned COVID-19 trial
03/17/20 Credit Suisse
Insmed price target lowered to $42 from $49 at Credit Suisse
02/04/20 Goldman Sachs
Insmed price target raised to $46 from $33 at Goldman Sachs
01/15/20 JMP Securities
Insmed poised for 'exciting' 2020, says JMP Securities
MRK Merck
$84.18 /

+0.93 (+1.12%)

09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
08/04/20 Piper Sandler
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/09/20 Morgan Stanley
Elekta price target raised to SEK 91 from SEK 86 at Morgan Stanley
09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
RPTX Repare Therapeutics
$33.20 /

+3.23 (+10.78%)

07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Morgan Stanley
Repare Therapeutics initiated with an Overweight at Morgan Stanley
07/14/20 Goldman Sachs
Repare Therapeutics initiated with a Neutral at Goldman Sachs
07/14/20 Piper Sandler
Repare Therapeutics initiated with an Overweight at Piper Sandler
BLI Berkeley Lights
$60.12 /

+1.04 (+1.76%)

08/11/20
Fly Intel: Top five analyst initiations
08/11/20 JPMorgan
JPMorgan starts 'industry pioneer' Berkeley Lights at Overweight
08/11/20 Morgan Stanley
Berkeley Lights initiated with an Equal Weight at Morgan Stanley
08/11/20 JPMorgan
Berkeley Lights initiated with an Overweight at JPMorgan
DXCM DexCom
$393.34 /

+9.62 (+2.51%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
LEGN Legend Biotech
$32.29 /

+1.24 (+3.99%)

07/01/20 JPMorgan
Legend Biotech initiated with an Overweight at JPMorgan
07/01/20 Jefferies
Legend Biotech initiated with a Buy at Jefferies
06/30/20 Morgan Stanley
Legend Biotech initiated with an Overweight at Morgan Stanley
IRTC iRhythm
$220.30 /

+10.57 (+5.04%)

09/11/20 Needham
iRhythm initiated with a Hold at Needham
09/01/20 Baird
iRhythm initiated with a Neutral at Baird
08/26/20 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/25/20 Citi
iRhythm price target raised to $250 from $215 at Citi
HOOK Hookipa Pharma
$11.18 /

+1.55 (+16.10%)

09/27/19 H.C. Wainwright
Hookipa Pharma initiated with a Buy at H.C. Wainwright
BLUE Bluebird Bio
$54.06 /

+0.77 (+1.44%)

08/06/20 Wedbush
Bluebird Bio price target lowered to $81 from $89 at Wedbush
06/12/20 Piper Sandler
Bluebird Bio update 'modestly positive,' says Piper Sandler
06/10/20 Stifel
Stifel says Bluebird setup 'downside biased,' Crispr's 'upside biased' into EHA
05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
SRPT Sarepta
$138.60 /

+7.935 (+6.07%)

09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/10/20 Piper Sandler
Sarepta filing for SRP-9001 could still meet expectations, says Piper Sandler
09/10/20 Mizuho
Sarepta potential study delay 'largely immaterial,' says Mizuho
09/10/20 Goldman Sachs
Sarepta Phase 3 timelines 'could remain intact,' says Goldman Sachs
MRNS Marinus Pharmaceuticals
$2.10 /

+0.1 (+5.00%)

09/15/20 Oppenheimer
Marinus Pharmaceuticals price target raised to $7 from $6 at Oppenheimer
09/15/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $8 from $6 at Cantor Fitzgerald
09/15/20 Jefferies
Marinus Pharmaceuticals price target raised to $6 from $4 at Jefferies
09/15/20 JMP Securities
Marinus Pharmaceuticals price target raised to $7 from $4 at JMP Securities
ISRG Intuitive Surgical
$717.15 /

+14.79 (+2.11%)

09/11/20 Wolfe Research
Intuitive Surgical initiated with an Outperform at Wolfe Research
09/08/20 BofA
Intuitive Surgical downgraded to Neutral from Buy at BofA
09/08/20 BofA
Intuitive Surgical downgraded to Neutral from Buy at BofA
09/01/20 Baird
Intuitive Surgical initiated with a Neutral at Baird
TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

SRPT Sarepta
$138.60 /

+7.935 (+6.07%)

RPTX Repare Therapeutics
$33.20 /

+3.23 (+10.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RGNX Regenxbio
$28.67 /

+1.65 (+6.11%)

MRNS Marinus Pharmaceuticals
$2.10 /

+0.1 (+5.00%)

MRK Merck
$84.18 /

+0.93 (+1.12%)

MCK McKesson
$150.95 /

+0.495 (+0.33%)

LEGN Legend Biotech
$32.29 /

+1.24 (+3.99%)

ISRG Intuitive Surgical
$717.15 /

+14.79 (+2.11%)

IRTC iRhythm
$220.30 /

+10.57 (+5.04%)

INSM Insmed
$30.38 /

+2.03 (+7.16%)

HOOK Hookipa Pharma
$11.18 /

+1.55 (+16.10%)

HAE Haemonetics
$89.58 /

+0.795 (+0.90%)

DXCM DexCom
$393.34 /

+9.62 (+2.51%)

CVS CVS Health
$57.93 /

+0.52 (+0.91%)

BLUE Bluebird Bio
$54.06 /

+0.77 (+1.44%)

BLI Berkeley Lights
$60.12 /

+1.04 (+1.76%)

  • 19
    Aug
  • 07
    Aug
  • 17
    Jul
  • 19
    Jun
  • 05
    Jun
  • 29
    May
  • 19
    May
  • 05
    May
  • 11
    Dec
TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

TAK Takeda Pharmaceutical
$18.37 /

+0.03 (+0.16%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRK Merck
$84.18 /

+0.93 (+1.12%)

MCK McKesson
$150.95 /

+0.495 (+0.33%)

IRTC iRhythm
$220.30 /

+10.57 (+5.04%)

DXCM DexCom
$393.34 /

+9.62 (+2.51%)

CVS CVS Health
$57.93 /

+0.52 (+0.91%)

TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

TAK Takeda Pharmaceutical
$18.37 /

+0.03 (+0.16%)

SRPT Sarepta
$138.60 /

+7.935 (+6.07%)

RPTX Repare Therapeutics
$33.20 /

+3.23 (+10.78%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MRNS Marinus Pharmaceuticals
$2.10 /

+0.1 (+5.00%)

MRK Merck
$84.18 /

+0.93 (+1.12%)

MCK McKesson
$150.95 /

+0.495 (+0.33%)

LEGN Legend Biotech
$32.29 /

+1.24 (+3.99%)

ISRG Intuitive Surgical
$717.15 /

+14.79 (+2.11%)

FRLN Freeline
$17.00 /

-0.005 (-0.03%)

DXCM DexCom
$393.34 /

+9.62 (+2.51%)

CVS CVS Health
$57.93 /

+0.52 (+0.91%)

BLUE Bluebird Bio
$54.06 /

+0.77 (+1.44%)

BLI Berkeley Lights
$60.12 /

+1.04 (+1.76%)

TMO Thermo Fisher
$433.94 /

+3.4 (+0.79%)

TAK Takeda Pharmaceutical
$18.37 /

+0.03 (+0.16%)

MRK Merck
$84.18 /

+0.93 (+1.12%)

MCK McKesson
$150.95 /

+0.495 (+0.33%)

ISRG Intuitive Surgical
$717.15 /

+14.79 (+2.11%)

HOOK Hookipa Pharma
$11.18 /

+1.55 (+16.10%)

CVS CVS Health
$57.93 /

+0.52 (+0.91%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/10/20
09/10
04:55
09/10/20
04:55
PHG

Philips

$47.66 /

+0.545 (+1.16%)

, FSNUY

Fresenius SE

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

, SONVY

Sonova

$0.00 /

+ (+0.00%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

, CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

, AMBBY

Ambu

$0.00 /

+ (+0.00%)

, TCHBF

Tecan

$0.00 /

+ (+0.00%)

, CLPBY

Coloplast

$0.00 /

+ (+0.00%)

, SNN

Smith & Nephew

$40.91 /

+0.73 (+1.82%)

, AMFPF

Amplifon

$0.00 /

+ (+0.00%)

, EKTAY

Elekta

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SAUHY

Straumann

$0.00 /

+ (+0.00%)

, HKMPY

Use HKMPF

$0.00 /

+ (+0.00%)

, GRRMF

Gerresheimer

$0.00 /

+ (+0.00%)

17th European Medtech…

17th European Medtech & Healthcare Services Virtual Conference on September 9-10. Webcast Link

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.66 /

+0.545 (+1.16%)

PHG Philips
$47.66 /

+0.545 (+1.16%)

09/01/20 UBS
Philips price target lowered to EUR 47 from EUR 48 at UBS
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
07/28/20 Societe Generale
Philips initiated with a Buy at Societe Generale
07/21/20 JPMorgan
Philips price target raised to EUR 39.50 from EUR 36.80 at JPMorgan
FSNUY Fresenius SE
$0.00 /

+ (+0.00%)

08/14/20 JPMorgan
Fresenius SE price target lowered to EUR 60.40 from EUR 66.30 at JPMorgan
08/05/20 Jefferies
Fresenius SE downgraded to Underperform from Hold at Jefferies
07/24/20 Deutsche Bank
Deutsche Bank backs Buy on Fresenius ahead of Q2 results
06/17/20 UBS
Fresenius SE price target lowered to EUR 47 from EUR 49 at UBS
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
08/12/20 Barclays
Siemens Healthineers price target raised to EUR 40 from EUR 38 at Barclays
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

08/25/20 Morgan Stanley
GN Store Nord price target raised to DKK 414 from DKK 298 at Morgan Stanley
08/20/20 Credit Suisse
GN Store Nord price target raised to DKK 465 from DKK 420 at Credit Suisse
08/20/20 JPMorgan
GN Store Nord price target raised to DKK 413 from DKK 353 at JPMorgan
08/05/20 Credit Suisse
GN Store Nord upgraded to Outperform from Underperform at Credit Suisse
SONVY Sonova
$0.00 /

+ (+0.00%)

09/02/20 UBS
Sonova price target raised to CHF 225 from CHF 220 at UBS
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
07/27/20 Morgan Stanley
Sonova upgraded to Equal Weight from Underweight at Morgan Stanley
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
05/26/20 Commerzbank
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank
05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
AMBBY Ambu
$0.00 /

+ (+0.00%)

08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
08/27/20 SEB Equities
Ambu upgraded to Buy from Hold at SEB Equities
05/06/20 JPMorgan
Ambu downgraded to Neutral from Overweight at JPMorgan
05/06/20 Danske Bank
Ambu upgraded to Hold from Sell at Danske Bank
TCHBF Tecan
$0.00 /

+ (+0.00%)

08/27/20 Berenberg
Berenberg sees Tecan at 'toppy levels,' downgrades to Hold
08/27/20 Berenberg
Tecan downgraded to Hold from Buy at Berenberg
08/17/20 UBS
Tecan price target raised to CHF 455 from CHF 375 at UBS
08/14/20 Credit Suisse
Tecan price target raised to CHF 425 from CHF 305 at Credit Suisse
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
SNN Smith & Nephew
$40.91 /

+0.73 (+1.82%)

07/31/20 Berenberg
Smith & Nephew price target lowered to 2,090 GBp from 2,150 GBp at Berenberg
07/30/20 JPMorgan
Smith & Nephew price target lowered to 1,553 GBp from 1,633 GBp at JPMorgan
07/30/20 Morgan Stanley
Smith & Nephew price target lowered to 1,940 GBp at Morgan Stanley
07/29/20 BofA
Smith & Nephew upgraded to Buy at BofA as surgical volumes recover
AMFPF Amplifon
$0.00 /

+ (+0.00%)

09/03/20 Jefferies
Amplifon upgraded to Buy from Hold at Jefferies
04/09/20 Jefferies
Amplifon price target lowered to EUR 18.10 from EUR 26 at Jefferies
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/09/20 Morgan Stanley
Elekta price target raised to SEK 91 from SEK 86 at Morgan Stanley
09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
SAUHY Straumann
$0.00 /

+ (+0.00%)

08/25/20 UBS
Straumann price target raised to CHF 890 from CHF 800 at UBS
08/24/20 Deutsche Bank
Straumann downgraded to Hold from Buy at Deutsche Bank
08/17/20 Berenberg
Straumann price target raised to CHF 770 from CHF 760 at Berenberg
08/14/20 JPMorgan
Straumann price target raised to CHF 668 from CHF 583 at JPMorgan
HKMPY Use HKMPF
$0.00 /

+ (+0.00%)

04/02/20 JPMorgan
Hikma upgraded to Overweight from Neutral at JPMorgan
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
GRRMF Gerresheimer
$0.00 /

+ (+0.00%)

07/29/20 Berenberg
Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg
SNN Smith & Nephew
$40.91 /

+0.73 (+1.82%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.66 /

+0.545 (+1.16%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.66 /

+0.545 (+1.16%)

Recommendations
Elekta price target raised to SEK 91 from SEK 86 at Morgan Stanley » 13:21
09/09/20
09/09
13:21
09/09/20
13:21
EKTAY

Elekta

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Michael Jungling raised the firm's price target on Elekta to SEK 91 from SEK 86 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
Conference/Events
Goldman Sachs to hold a virtual conference » 07:58
09/09/20
09/09
07:58
09/09/20
07:58
PHG

Philips

$47.13 /

+0.48 (+1.03%)

, FSNUY

Fresenius SE

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

, SONVY

Sonova

$0.00 /

+ (+0.00%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

, CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

, AMBBY

Ambu

$0.00 /

+ (+0.00%)

, TCHBF

Tecan

$0.00 /

+ (+0.00%)

, CLPBY

Coloplast

$0.00 /

+ (+0.00%)

, SNN

Smith & Nephew

$40.18 /

+0.06 (+0.15%)

, AMFPF

Amplifon

$0.00 /

+ (+0.00%)

, EKTAY

Elekta

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SAUHY

Straumann

$0.00 /

+ (+0.00%)

, HKMPY

Use HKMPF

$0.00 /

+ (+0.00%)

, GRRMF

Gerresheimer

$0.00 /

+ (+0.00%)

17th European Medtech…

17th European Medtech & Healthcare Services Virtual Conference on September 9-10. Webcast Link

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.13 /

+0.48 (+1.03%)

PHG Philips
$47.13 /

+0.48 (+1.03%)

09/01/20 UBS
Philips price target lowered to EUR 47 from EUR 48 at UBS
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
07/28/20 Societe Generale
Philips initiated with a Buy at Societe Generale
07/21/20 JPMorgan
Philips price target raised to EUR 39.50 from EUR 36.80 at JPMorgan
FSNUY Fresenius SE
$0.00 /

+ (+0.00%)

08/14/20 JPMorgan
Fresenius SE price target lowered to EUR 60.40 from EUR 66.30 at JPMorgan
08/05/20 Jefferies
Fresenius SE downgraded to Underperform from Hold at Jefferies
07/24/20 Deutsche Bank
Deutsche Bank backs Buy on Fresenius ahead of Q2 results
06/17/20 UBS
Fresenius SE price target lowered to EUR 47 from EUR 49 at UBS
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
08/12/20 Barclays
Siemens Healthineers price target raised to EUR 40 from EUR 38 at Barclays
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

08/25/20 Morgan Stanley
GN Store Nord price target raised to DKK 414 from DKK 298 at Morgan Stanley
08/20/20 Credit Suisse
GN Store Nord price target raised to DKK 465 from DKK 420 at Credit Suisse
08/20/20 JPMorgan
GN Store Nord price target raised to DKK 413 from DKK 353 at JPMorgan
08/05/20 Credit Suisse
GN Store Nord upgraded to Outperform from Underperform at Credit Suisse
SONVY Sonova
$0.00 /

+ (+0.00%)

09/02/20 UBS
Sonova price target raised to CHF 225 from CHF 220 at UBS
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
08/27/20 Redburn
Sonova upgraded to Buy from Neutral at Redburn
07/27/20 Morgan Stanley
Sonova upgraded to Equal Weight from Underweight at Morgan Stanley
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

07/17/20 Berenberg
Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg
07/16/20 Deutsche Bank
Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
05/26/20 Commerzbank
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank
05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
AMBBY Ambu
$0.00 /

+ (+0.00%)

08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
08/27/20 SEB Equities
Ambu upgraded to Buy from Hold at SEB Equities
05/06/20 JPMorgan
Ambu downgraded to Neutral from Overweight at JPMorgan
05/06/20 Danske Bank
Ambu upgraded to Hold from Sell at Danske Bank
TCHBF Tecan
$0.00 /

+ (+0.00%)

08/27/20 Berenberg
Berenberg sees Tecan at 'toppy levels,' downgrades to Hold
08/27/20 Berenberg
Tecan downgraded to Hold from Buy at Berenberg
08/17/20 UBS
Tecan price target raised to CHF 455 from CHF 375 at UBS
08/14/20 Credit Suisse
Tecan price target raised to CHF 425 from CHF 305 at Credit Suisse
CLPBY Coloplast
$0.00 /

+ (+0.00%)

08/19/20 JPMorgan
Coloplast price target lowered to DKK 886 from DKK 920 at JPMorgan
08/19/20 Morgan Stanley
Coloplast price target lowered to DKK 822 from DKK 843 at Morgan Stanley
08/11/20 Nordea
Coloplast downgraded to Sell from Hold at Nordea
05/13/20 Kepler Cheuvreux
Coloplast upgraded to Hold from Reduce at Kepler Cheuvreux
SNN Smith & Nephew
$40.18 /

+0.06 (+0.15%)

07/31/20 Berenberg
Smith & Nephew price target lowered to 2,090 GBp from 2,150 GBp at Berenberg
07/30/20 JPMorgan
Smith & Nephew price target lowered to 1,553 GBp from 1,633 GBp at JPMorgan
07/30/20 Morgan Stanley
Smith & Nephew price target lowered to 1,940 GBp at Morgan Stanley
07/29/20 BofA
Smith & Nephew upgraded to Buy at BofA as surgical volumes recover
AMFPF Amplifon
$0.00 /

+ (+0.00%)

09/03/20 Jefferies
Amplifon upgraded to Buy from Hold at Jefferies
04/09/20 Jefferies
Amplifon price target lowered to EUR 18.10 from EUR 26 at Jefferies
09/10/19 Jefferies
Amplifon downgraded to Hold from Buy at Jefferies
EKTAY Elekta
$0.00 /

+ (+0.00%)

09/03/20 Berenberg
Elekta price target raised to SEK 124 from SEK 100 at Berenberg
08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
RHHBY Roche
$0.00 /

+ (+0.00%)

08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
SAUHY Straumann
$0.00 /

+ (+0.00%)

08/25/20 UBS
Straumann price target raised to CHF 890 from CHF 800 at UBS
08/24/20 Deutsche Bank
Straumann downgraded to Hold from Buy at Deutsche Bank
08/17/20 Berenberg
Straumann price target raised to CHF 770 from CHF 760 at Berenberg
08/14/20 JPMorgan
Straumann price target raised to CHF 668 from CHF 583 at JPMorgan
HKMPY Use HKMPF
$0.00 /

+ (+0.00%)

04/02/20 JPMorgan
Hikma upgraded to Overweight from Neutral at JPMorgan
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
GRRMF Gerresheimer
$0.00 /

+ (+0.00%)

07/29/20 Berenberg
Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg
SNN Smith & Nephew
$40.18 /

+0.06 (+0.15%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.13 /

+0.48 (+1.03%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PHG Philips
$47.13 /

+0.48 (+1.03%)

Recommendations
Elekta price target raised to SEK 124 from SEK 100 at Berenberg » 12:48
09/03/20
09/03
12:48
09/03/20
12:48
EKTAY

Elekta

$0.00 /

+ (+0.00%)

Berenberg analyst Scott…

Berenberg analyst Scott Bardo raised the firm's price target on Elekta to SEK 124 from SEK 100 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

08/27/20 JPMorgan
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan
08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
07/29/20 Morgan Stanley
Elekta upgraded to Equal Weight from Underweight at Morgan Stanley
Recommendations
Elekta price target raised to SEK 88 from SEK 75 at JPMorgan » 12:50
08/27/20
08/27
12:50
08/27/20
12:50
EKTAY

Elekta

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington raised the firm's price target on Elekta to SEK 88 from SEK 75 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

08/24/20 JPMorgan
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan
08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
07/29/20 Morgan Stanley
Elekta upgraded to Equal Weight from Underweight at Morgan Stanley
06/01/20 JPMorgan
Elekta price target lowered to SEK 75 from SEK 78 at JPMorgan
Over a quarter ago
Recommendations
Elekta not expected to provide FY guidance update in Q1 report, says JPMorgan » 13:12
08/24/20
08/24
13:12
08/24/20
13:12
EKTAY

Elekta

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington reiterated a Neutral rating and SEK 75 price target on Elekta ahead of the company's Q1 results. Adlington does not expect the company to provide an update on full year or mid-term guidance, in particular with the CEO position vacant.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

08/03/20 JPMorgan
Elekta upgraded to Neutral from Underweight at JPMorgan
07/29/20 Morgan Stanley
Elekta upgraded to Equal Weight from Underweight at Morgan Stanley
06/01/20 JPMorgan
Elekta price target lowered to SEK 75 from SEK 78 at JPMorgan
05/12/20 Berenberg
Berenberg backs Buy on Elekta amid slowdown in accelerator installations
Upgrade
Elekta upgraded to Neutral from Underweight at JPMorgan » 06:35
08/03/20
08/03
06:35
08/03/20
06:35
EKTAY

Elekta

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

JPMorgan analyst David Adlington upgraded Elekta (EKTAY) to Neutral from Underweight with an unchanged price target of SEK 75. Siemens Healthineers announced it is acquiring Elekta's key competitor Varian (VAR), Adlington tells investors in a research note. Elekta shareholders "now face a double-edged dilemma," says the analyst. On the upside, external interest in the market demonstrates perceived strategic value, but on the downside, Elekta potentially faces a significantly larger competitor, according to Adlington. Adlington upgraded Elekta to Neutral saying that in the near term, investors could move to assume a greater chance of further consolidation in the sector.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

07/29/20 Morgan Stanley
Elekta upgraded to Equal Weight from Underweight at Morgan Stanley
06/01/20 JPMorgan
Elekta price target lowered to SEK 75 from SEK 78 at JPMorgan
05/12/20 Berenberg
Berenberg backs Buy on Elekta amid slowdown in accelerator installations
05/07/20 UBS
Elekta downgraded to Neutral from Buy at UBS
Upgrade
Elekta upgraded to Equal Weight from Underweight at Morgan Stanley » 05:20
07/29/20
07/29
05:20
07/29/20
05:20
EKTAY

Elekta

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Michael Jungling upgraded Elekta to Equal Weight from Underweight with an SEK 86 price target.

ShowHide Related Items >><<
EKTAY Elekta
$0.00 /

+ (+0.00%)

06/01/20 JPMorgan
Elekta price target lowered to SEK 75 from SEK 78 at JPMorgan
05/12/20 Berenberg
Berenberg backs Buy on Elekta amid slowdown in accelerator installations
05/07/20 UBS
Elekta downgraded to Neutral from Buy at UBS
04/29/20 JPMorgan
Elekta price target lowered to SEK 78 from SEK 118 at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.